Journals / Androloji Bülteni / 2020 / Cilt: 22 - Sayı: 1

Current approaches in the treatment of prematüre ejaculation

Prematür ejakülasyon tedavisinde güncel yaklaşımlar

Pages
20–27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Eutectic lidocaine/prilocaine metered-dose aerosol spray may be an alternative for off-label SSRI treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTİVES: To review current developments in the treatment of prematüre ejaculation MATERIAL AND METHODS: Research studies, reviews, related texts related to premature ejaculation therapy obtained from electronic academic databases such as Web of Science, Pubmed, Scopus and Google Scholar were reviewed.
📊
Key Findings & Data:PDE5i drugs alone or in combination with SSRIs are more effective in the treatment of lifelong PE.
💡
Conclusion & Impact:Eutectic lidocaine/prilocaine metered-dose aerosol spray may be an alternative for off-label SSRI treatment
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTİVES: To review current developments in the treatment of prematüre ejaculation MATERIAL AND METHODS: Research studies, reviews, related texts related to premature ejaculation therapy obtained from electronic academic databases such as Web of Science, Pubmed, Scopus and Google Scholar were reviewed. RESULTS: The European Medicine Agency (EMA) recommends shortacting SSRI dapoxetine and eutectic lidocaine/prilocaine metered-dose aerosol spray for the on-demand treatment of PE. PDE5i drugs alone or in combination with SSRIs are more effective in the treatment of lifelong PE. Topical anesthetics and combinations of PD5i or SSRI may be effective in the treatment of anteportal PE. Pharmacological therapies combined with psychosexual/behavioral therapies may be useful in the treatment of acquired PE. CONCLUSIONS: Pharmacotherapy should be the first option for lifelong PE. Combined pharmacological therapies with peripheral and central effects may be beneficial, especially in men with anteportal PE. Eutectic lidocaine/prilocaine metered-dose aerosol spray may be an alternative for off-label SSRI treatment

Özet

AMAÇ: Prematür ejakülasyon tedavisinde güncel gelişmelerin gözden geçirilmesi GEREÇ VE YÖNTEM: Web of Science, Pubmed, Scopus ve Google Scholar gibi elektronik akademik veri tabanları aramalarından elde edilen prematür ejakülasyon tedavisi ile ilgili araştırma çalışmaları, derleme ve ilgili metinlerin gözden geçirilmesi ile hazırlanmıştır. BULGULAR: Avrupa İlaç Ajansı (EMA) kısa etkili SSRİ olan dapoksetin ve ötektik lidokain/prilokain doz ayarlamalı aerosol sprey’i PE’nin gerektiğinde tedavisi için önermektedir. Yaşam boyu PE tedavisinde PDE5i ilaçların tek başına veya SSRİ’lerle kombine şekilde kullanılması daha etkindir. Anteportal PE tedavisinde topikal anestetikler ile PD5i veya SSRİ kombinasyonları etkili olabilir. Kazanılmış PE tedavisinde psikoseksüel/davranış tedavileri ile kombine farmakolojik tedaviler yararlı olabilir. SONUÇLAR: Yaşam boyu PE tedavisinde ilk seçenek farmakoterapi olmalıdır. Özellikle anteportal PE’si olan erkeklerde periferik ve santral etkili kombine farmakolojik tedaviler yararlı olabilir. Ötektik lidokain/ prilokain doz kontrollü sprey, endikasyon dışı kullanılan SSRİ tedavisi için alternatif olabilir.

🔖

Cite This Article

AŞÇI, R. (2020). Current approaches in the treatment of prematüre ejaculation. Androloji Bülteni, Cilt: 22 - Sayı: 1, 20–27. https://ajindex.com/articles/141481

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med 2014;2:41–59. [CrossRef] 2. Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF, et al. Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. J Sex Med 2011;8:540–8. [CrossRef] 3. Gao J, Zhang X, Su P, Liu J, Xia L, Yang J, et al. Prevalence and factors associated with the complaint of premature ejaculation and the four premature ejaculation syndromes: a large observational study in China. J Sex Med 2013;10:1874–81. [CrossRef] 4. McMahon CG, Jannini EA, Serefoglu EC, Hellstrom WJ. The pathophysiology of acquired premature ejaculation. Transl Androl Urol 2016;5:434–49. [CrossRef] 5. Waldinger MD. The pathophysiology of lifelong premature ejaculation. Transl Androl Urol 2016;5:424–33. [CrossRef] 6. Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. Interplay Between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med 2015;12:2291–300. [CrossRef] 7. Clement P, Giuliano F. Physiology and Pharmacology of Ejaculation. Basic Clin Pharmacol Toxicol 2016;119(Suppl 3):18– 25. [CrossRef] 8. Gur S, Sikka SC. The characterization, current medications, and promising therapeutics targets for premature ejaculation. Andrology 2015;3:424–42. [CrossRef] 9. Andersson KE, Abdel-Hamid IA. Therapeutic targets for premature ejaculation. Maturitas 2011;70:26–33. [CrossRef] 10. Saitz TR, Serefoglu EC. Advances in understanding and treating premature ejaculation. Nat Rev Urol 2015;12:629–640. [CrossRef] 11. Cooper K, Martyn-St James M, Kaltenthaler E, Dickinson K, Cantrell A, Wylie K, et al. Behavioral therapies for management of premature ejaculation: a systematic review. J Sex Med 2015;3:174– 188. [CrossRef] 12. Bao B, Shang J, Wang J, Dai H, Li X, Zhang K, et al. Efficacy and safety of behavioral therapy for premature ejaculation: Protocol for a systematic review. Medicine (Baltimore) 2019;98:e14056. [CrossRef] 13. Castiglione F, Albersen M, Hedlund P, Gratzke C, Salonia A, Giuliano F. Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis. Eur Urol 2016;69:904–16.